- Clarification 14 January 2021
How researchers are revamping antimicrobial drugs
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Nature 586, S55-S56 (2020)
This article is part of Nature Outlook: Antimicrobial resistance, an editorially independent supplement produced with the financial support of third parties. About this content.
Updates & Corrections
Clarification 14 January 2021: The caption for the image showing Kim Lewis has been amended to also name postdoc Yu Imai.
Du, D. et al. Nature Rev. Microbiol. 16, 523–539 (2018).
Marshall, R. L. et al. mBio https://doi.org/10.1128/mBio.01340-20 (2020).
Imai, Y. et al. Nature 576, 459–464 (2019).
Ling, L. L. et al. Nature 517, 455–459 (2015).
Smith, T. C. et al. Proc. Natl Acad. Sci. 117, 18744–18753 (2020).